Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
RGEN | REPLIGEN CORP | Director | $482K | Aug 1, 2024 | ||
STIM | Neuronetics, Inc. | Director | $232K | +$85.1K | +58% | Sep 5, 2024 |
GTHX | G1 Therapeutics, Inc. | Director | $0 | Sep 18, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|